Annual report pursuant to Section 13 and 15(d)

Investments and Fair Value of Financial Instruments

v3.20.4
Investments and Fair Value of Financial Instruments
12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Investments and Fair Value of Financial Instruments

Note 4 – Investments and Fair Value of Financial Instruments

 

Investments consist of available-for-sale equity securities, which are carried at fair value. Interest and dividends on investments are included in finance income (expense).

 

As of December 31, 2020, the Company did not have any investments. The following table summarizes, by major security type, the Company’s investments as of December 31, 2019:

 

      December 31, 2019  
      Amortized
Cost
    Carrying
Value
 
  Mutual fund, available-for-sale     $ 8,198     $ 8,203  
  Total     $ 8,198     $ 8,203  

 

The following table summarizes the fair value of our financial assets and liabilities that were accounted for at fair value on a recurring basis, by level within the fair value hierarchy, as of December 31, 2020 and 2019:

 

    December 31, 2020  
    Level 1     Level 2     Level 3     Fair Value  
Assets                        
Investments   $ -     $ -     $ -     $ -  
                                 
Liabilities                                
Contingent royalty obligation   $ -     $ -     $ 1,617     $ 1,617  

 

    December 31, 2019  
    Level 1     Level 2     Level 3     Fair Value  
Assets                        
Investments   $ 8,203     $ -     $ -     $ 8,203  
                                 
Liabilities                                
Contingent royalty obligation   $ -     $ -     $ 1,872     $ 1,872  

 

Financial instruments with carrying values approximating fair value include cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued expenses, and certain other current liabilities, due to their short-term nature.

 

Contingent Royalty Obligation

 

In estimating the fair value of the Company’s contingent royalty obligation (see Note 9), the Company used the discounted cash flow method as of December 31, 2020 and 2019. Based on the fair value hierarchy, the Company classified contingent royalty obligation within Level 3 because valuation inputs are based on projected revenues discounted to a present value.

 

The following table sets forth a summary of changes in the estimated fair value of the Company’s Level 3 contingent royalty obligation for the years ended December 31, 2020 and 2019:

 

    Fair Value Measurements of Contingent Royalty Obligation (Level 3)  
Balance at December 31, 2018   $ 1,953  
Change in estimated fair value of contingent royalty obligation     (81 )
Balance at December 31, 2019     1,872  
Change in estimated fair value of contingent royalty obligation     (255 )
Balance at December 31, 2020   $ 1,617  

 

The contingent royalty obligation is re-measured at each balance sheet date using several assumptions, including the following: 1) estimated sales growth, 2) length of product cycle, 3) patent life, 4) discount rate (21% as of December 31, 2020 and 2019), and 5) rate of royalty payment (3% as of December 31, 2020 and 2019).

 

In accordance with ASC-820-10-50-2(g), the Company performed sensitivity analyses of the liability, which was classified as a Level 3 financial instrument. The contingent royalty obligation estimate may be significantly impacted by changes in assumptions used in these analyses. For example, the Company recalculated the fair value of the liability by applying a +/- 2% change to the input variable in the discounted cash flow model; the discount rate. A 2% decrease in the discount rate would increase the liability by approximately $260 and a 2% increase in the discount rate would decrease the liability by approximately $66.